Effects of social housing condition on the response of the Shionogi mouse mammary carcinoma (SC115) to chemotherapy

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1124-1128

  Kerr, Leslie R ^a   Grimm, Michelle S ^a   Andre Silva W ^a   Weinberg, Joanne ^a   Emerman, Joanne T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HORMONE RESPONSE; HOUSING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSOCIAL ENVIRONMENT; RISK FACTOR; SURVIVAL TIME; TUMOR VOLUME;

ANDROGENS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL DIVISION; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; HOUSING, ANIMAL; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; SOCIAL ENVIRONMENT; SOCIAL ISOLATION; STRESS, PSYCHOLOGICAL; TUMOR STEM CELLS;

EID: 0030940629     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Bloom, B. L., Asher, S. J., and White, S. W. Marital disruption as a Stressor: a review and analysis. Psychol. Bull., 55: 867-894, 1978.
2. Cooper, C. L., Cooper, R., and Faragher, E. B. Incidence and perception of psychosocial stress: the relationship with breast cancer. Psychol. Med., 19: 415-422, 1989.
3. Jensen, A. B. Psychological factors in breast cancer and their possible impact upon prognosis. Cancer Treat. Rev., 18: 191-210, 1991.
4. Levy, S., Herberman, R., Lippman, M., and d'Angelo, T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J. Clin. Oncol., 5: 348-353, 1987.
5. Scherge, H., and Blokmke, M. Associations between selected life events and cancer. Behav. Med., 14: 119-124, 1988.
6. Hislop, T. G., Waxier, N. E., Coldman, A. J., Elwood, J. M., and Kan, L. The prognostic significance of psychosocial factors in women with breast cancer. J. Chronic Dis., 40: 729-735, 1987.
7. Ramirez, A. J., Craig, T. K. J., Watson, J. P., Fentiman, I. S., North, W. R. S., and Rubens, R. D. Stress relapse of breast cancer. Br. Med. J., 298: 291-293, 1989.
8. Levy, S. M., Lee, J., Bagley, C., and Lippman, M. Survival hazards analysis in first recurrent breast cancer patients: seven-year follow-up. Psychosom. Med., 50: 520-528, 1988.
9. Greer, S., Morris, T., and Pettingale, L. W. Psychological response to breast cancer: effect on outcome. Lancet, 2: 785-787, 1979.
10. Greer, S., Moorey, S., and Baruch, J. Evaluation of adjuvant psychological therapy for clinically referred patients. Br. J. Cancer, 63: 257-260, 1991.
11. Levy, S. M. Behavioral factors contributing directly to progression of cancer. In: S. M. Levy (ed.), Behavior and Cancer, pp. 148-180. San Francisco: Jossey-Boss, 1985.
12. Northouse, L. L. Social support in patients' and husbands' adjustment to breast cancer. Nurs. Res., 37: 91-95, 1988.
13. Gruber, B. L., Hall, N. R., Hersh, S. P., and Dubois, P. Immune system and psychological changes in metastatic cancer patients while using ritualized, relaxation and guided imagery. Scand. J. Behav. Ther., 17: 25-46, 1988.
14. Spiegel, D., Bloom, J. R., Kraemer, H. C., and Gottheil, E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2: 888-891, 1989.
15. Pettingale, K. W., Morris, T., Greer, S., and Haybittle, J. Mental attitudes to cancer: an additional prognostic factor. Lancet, 7: 750, 1985.
16. Rogentine, G., VanKammen, D., Fox, B., Docherty, J. R., Rosenblat, S. E., Boyd, S. C., and Bunney, W. E. Psychological factors in the prognosis of malignant melanoma: a prospective study. Psychosom. Med., 41: 647-655, 1979.
17. Temoshock, L. Personality, coping style, emotion and cancer: towards an integrative model. Cancer Surv., 6: 545-567, 1987.
18. Cassileth, B. R., Lusk, E. J., Miller, D. S., Brown, L. L., and Miller, C. Psychosocial correlates of survival in advanced malignant disease. N. Engl. J. Med., 12: 1551-1555, 1985.
19. Ewertz, M. Bereavement and breast cancer. Br. J. Cancer, 53: 701-703, 1986.
20. Jamison, R. N., Burish, T. G., and Wallston, K. A. Psychogenic factors in predicting survival of breast cancer patients. J. Clin. Oncol., 5: 768-772, 1987.
21. Muslin, H. L., Gyarfas, K., and Pieper, W. J. Separation experience and cancer of the breast. Ann. NY Acad. Sci., 725: 802-806, 1966.
22. Priestman, T. J., Priestman, S. G., and Bradshaw, C. Stress and breast cancer. Br. J. Cancer, 51: 493-498, 1985.
23. Barraclough, J., Pinder, P., Cruddas, M., Osmond, C., Taylor, I., and Perry, M. Life events and breast cancer prognosis. Br. Med. J., 304: 1078-1081, 1992.
24. Linn, M. W., Linn, B. S., and Harris, R. Effects of counseling for late stage cancer patients. Cancer (Phila.), 49: 1048-1055, 1982.
25. Amkraut, A., and Solomon, G. F. Stress and murine sarcoma virus (Maloney)-induced tumors. Cancer Res., 32: 1428-1433, 1972.
26. Baker, D. G., and Jahn, A. The influence of a chronic environmental stress on radiation carcinogenesis. Radiat. Res., 68: 449-458, 1976.
27. Riley, V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science (Washington DC), 272: 1100-1109, 1981.
28. Riley, V., Fitzmaurice, M. A., and Spackman, D. H. Psychoneuroimmunologic factors in neoplasia: studies in animals. In: R. Ader (ed.), Psychoneuroimmunology, pp. 31-102. New York: Academic Press, Inc., 1981.
29. Sklar, L. S., and Anisman, H. Stress and coping factors influence tumor growth. Science (Washington DC), 205: 513-515, 1979.
30. Solomon, G. F., Amkraut, A. A., and Rubin, R. T. Neuroendocrine aspects of immune response and their implications for stress effects on tumor immunity. Cancer Detect. Prev., 2: 197-224, 1979.
31. Steplewski, Z., Vogel, W. H., Ehya, H., Poropatich, C., and Smith, J. M. Effects of restraint stress on inoculated tumor growth and immune response in rats. Cancer Res., 45: 5128-5133, 1985.
32. Sklar, L. S., and Anisman, H. Social stress influences tumor growth. Psychosom. Med., 42: 347-365, 1980.
33. Steplewski, Z., Robinson Goldman, P., and Vogel, W. H. Effect of housing stress on the formation and development of tumors in rats. Cancer Lett., 34: 257-261, 1987.
34. Weinberg, J., and Emerman, J. T. Effects of psychosocial Stressors on mouse mammary tumor growth. Brain Behav. Immun., 3: 234-246, 1989.
35. Newberry, B. H., Gildow, J., Wogan, J., and Reese, R. L. Inhibition of Huggins tumors by forced restraint. Psychosom. Med., 38: 155-162, 1976.
36. Nieburgs, H. E., Weiss, J., Navarette, M., Strax, P., Teirstein, A., Grillione, G., and Siedlecki, B. The role of stress in human and experimental oncogenesis. Cancer Detect. Prev., 2: 307-336, 1979.
37. Grimm, M. S., Emerman, J. T., and Weinberg, J. Effects of social housing condition and behavior on growth of the Shionogi mouse mammary carcinoma. Physiol. Behav., 59: 633-642, 1996.
38. Lichtman, R. R., Taylor, S. E., and Wood, J. V. Social support and marital adjustment after breast cancer. J. Psychosoc. Oncol., 5: 47-74, 1987.
39. Waxler-Monison, N., Hislop, T. G., Mears, B., and Ran, L. Effects of social relationships on survival for women with breast cancer: a prospective study. Soc. Sci. Med., 33: 177-183, 1991.
40. Grossarth-Maticek, R., and Eysenck, H. J. Length of survival and lymphocyte percentage in women with mammary cancer as a function of psychotherapy. Psychol. Rep., 64: 315-321, 1989.
41. Spiegel, D., and Bloom, J. Group therapy and hypnosis reduce metastatic pain. Psychosom. Med., 45: 333-339, 1983.
42. Burish, T. G., Carey, M. P., Krozely, M. G., and Grteco, F. A. Conditioned side-effects induced by cancer chemotherapy: prevention through behavioral treatment. J. Consult. Clin. Psychol., 55: 42-48, 1987.
43. Cartei, G., Cartei, F., Cantone, A., Causarano, D., Genco, G., Tobaldin, A., Interlandi, G., and Giraldi, T. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer. J. Natl. Cancer Inst., 85: 794-800, 1993.
44. Giraldi, T., Perissin, L., Zorzet, S., and Rapozzi, V. Metastasis and neuroendocrine system in stressed mice. Ann. NY Acad. Sci., 650: 297-301, 1992.
45. Giraldi, T., Perissin, L., Zorzet, S., and Rapozzi, V. Stress, melatonin and tumor progression in mice, Ann. NY Acad. Sci., 719: 526-536, 1994.
46. Giraldi, T., Perissin, L., Zorzet, S., and Rapozzi, V. Stress and effectiveness of antitumor chemotherapy in mice. First International Congress of Stress, Bethesda, MD, 1994.
47. Perissin, L., Zorzet, S., Piccini, P., Rapozzi, V., and Giraldi, T. Effects of rotational stress on the effectiveness of cyclophosphamide and razoxane in mice bearing Lewis lung carcinoma. Clin. Exp. Metastasis, 9: 541-549, 1991.
48. Bruchovsky, N., and Rennie, P. S. Classification of dependent and autonomous variants of the Shionogi mammary carcinoma based on heterogeneous patterns of androgen binding. Cell, 12: 272-280, 1978.
49. King, R. B. J., and Yates. J. The use of cultured mammary tumor cells to study effects of steroid hormones. In: R. J. Richards and K. T. Rajan (eds.), Tissue Culture in Medical Research, pp. 221-227. New York: Pergamon Press, 1980.
50. Emerman, J. T., and Siemiatkowski, J. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy. Cancer Res., 44: 1327-1332, 1984.
51. Simpson-Herren, L., and Lloyd, H. H. Kinetic parameters and growth curves for experimental tumor systems. Cancer Chemother. Rep., 54: 143-174, 1970.
52. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc, 53: 457-481, 1958.
53. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. B., 33: 187-220, 1972.
54. Noguchi, S., Nichizawa, Y., Nakamura, N., Uchida, N., Yamaguchi, K., Sato, B., Kitamura, Y., and Matsumoto, K. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture. Cancer Res., 47: 263-268, 1987.
55. Watanabe, S., Nohno, T., Omukai, Y., Saito, T., and Senoo, T. Stimulatory effects of dexamethasone and indomethacin on growth of androgen-dependent Shionogi carcinoma 115 in the mouse. Cancer Lett., 16: 261-266, 1982.
56. Rowse, G. J., Rowan, R. E., Weinberg, J., and Emerman, J. T. Alterations in splenic natural killer cell activity induced by the Shionogi mouse mammary tumor. Cancer Lett., 54: 81-87, 1990.
57. Rowse, G. J., Weinberg, J., and Emerman, J. T. Role of natural killer cells in psychosocial stressor-induced changes in mouse mammary tumor growth. Cancer Res., 55:617-622, 1995.
58. Ihde, D. C., Bunn, P. A., Cohen, M. H., Dunnick, N. R., Eddy, J. L., and Minna, J. D. Effective treatment of hormonally-unresponsive metastatic carcinoma of the prostate with Adriamycin and cyclophosphamide: methods of documenting tumor response and progression. Cancer (Phila.), 45: 1300-1310, 1980.
59. Lloyd, R. E., Jones, S. E., and Salmon, S. E. Comparative trial of low-dose Adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer. Cancer (Phila.), 43: 60-65, 1979.
60. Rowse, G. J., Weinberg, J., Bellward, G. D., and Emerman, J. T. Endocrine mediation of psychosocial Stressor effects on mouse mammary tumor growth. Cancer Lett., 65: 85-93, 1992.
61. McClure, M. T., and Stupans, I. Hormonal perturbation as a possible mechanisms for the alteration of cytochrome P450 by cyclophosphamide. Biochem. Phramacol., 49: 1827-1836, 1995.
62. LeBlanc, G. A., and Waxman, D. J. Mechanisms of cyclophosphamide action on hepatic P-450 expression. Cancer Res., 50: 5720-5726, 1990.
63. Chang, T. K., and Waxman, D. J. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 α-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard. Cancer Res., 53: 2490-2497, 1993.
64. Johnston, J. O., Wright, C. L., and Holbert, G. W. Enzyme-activated inhibitors of steroidal hydroxylases. J. Steroid Biochem. Mol. Biol., 52: 17-34, 1995.
65. Parmiani, G. An expression of the variable clinical response to interleukin-2 and LAK cells. Immunol. Today, 11: 113-115, 1990.
66. Knuth, A., Wolfel, T., and Meyer Zum Buschenfelde, K-H. T. Cell responses to human malignant tumors. In: A. J. McMichael and W. F. Bodmer (eds.), A New Look at Tumor Immunology, pp. 39-54. New York: Cold Spring Harbor Laboratory, 1992.
67. Berd, D., Mastrangelo, M. J., Engstrom, P. F., Paul, A., and Maguire, H. Augmentation of the human immune response by cyclophosphamide. Cancer Res., 42: 4862-4866, 1982.
68. Cameron, R. B., Speiss, P. J., and Rosenberg, S. A. Synergistic antitumor activity of tumor infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action. J. Exp. Med., 171: 249-263, 1990.
69. Evans, R. Combination therapy by using cyclophosphamide and tumor-sensitized lymphocytes; a possible mechanism of action. J. Immunol., 130: 2511-2513, 1983.
70. Lafreniere, R., Borkenhagen, K., Bryant, L. D., and Ng, E. Tumor-infiltrating lymphocytes cultured in recombinant interleukin-2: enhancement of growth, cytotoxicity, and phenotypic expression of cytotoxic T-cell antigens by cyclophosphamide given intravenously prior to tumor harvest. J. Biol. Response Modif., 8: 238-251, 1989.
71. North, R. J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor induced suppressor cells. J. Exp. Med., 155: 1063-1074, 1982.
72. Sewell, H. F., Halbert, C. F., Robins, R. A., Galvin, A., Chan, S., and Blamey, R. W. Chemotherapy-induced differential changes in lymphocyte subsets and natural-killer-cell function in patients with advanced breast cancer. Int. J. Cancer, 55: 735-738, 1993.
73. Abdul Hamied, T. A., and Turk, J. L. Enhancement of interleukin-2 release in rats by treatment with bleomycin and Adriamycin in vivo. Cancer Immunol. Immunother., 25: 245-249, 1987.
74. Hasan, S. I., Blaney, B. A., and Turk, J. L. Effect of anticancer drugs on the release of interleukin-6 in vitro. Cancer Immunol. Immunother., 34: 228-232, 1992.
75. Kiberd, B. A., and Young, I. D. Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide. J. Lab. Clin. Med., 124: 470-472, 1994.
76. Brenner, B. G., and Margolese, R. G. The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer. Cancer (Phila.), 68: 482-488, 1991.
77. Stewart, L. S., Sewell, H. F., and Thomson, A. W. Combination chemo-immunotherapy: kinetics of in vivo and in vitro generation of natural killer cells and lymphokine activated kitter cells in the rat. Clin. Exp. Immunol., 79: 6-23, 1990.
78. Dye, E. S., and North, R. J. Macrophage accumulation in murine ascites tumors. I. Cytoxan-induced dominance of macrophages over tumor cells and the anti-tumor effect of endotoxin. J. Immunol., 725: 1650-1657, 1980.
79. Nugent, K. M., and Onofrio, J. M. Effect of alkylating agents on the clearance of Staphylococcus aureus from murine lungs. J. Leukocyte Biol., 41: 78-82, 1987.
80. Skipper, H. E. The cell cycle and chemotherapy of cancer. In: R. Baserga (ed.), The Cell Cycle and Cancer, pp. 355-390. New York: M. Dekker, 1971.